Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC) who were treated beyond progression in a randomized phase 2 dose-ranging trial Meeting Abstract


Authors: George, S. B.; Motzer, R. J.; Hammers, H.; Redman, B.; Kuzel, T.; Tykodi, S. S.; Plimack, E.; Jiang, L. J.; Waxman, L.; Rini, B. I.
Abstract Title: Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC) who were treated beyond progression in a randomized phase 2 dose-ranging trial
Meeting Title: 14th International Kidney Cancer Symposium (IKCS)
Journal Title: BJU International
Volume: 116
Issue: Suppl. 5
Meeting Dates: 2015 Nov 6-7
Meeting Location: Miami, FL
ISSN: 1464-4096
Publisher: Wiley Blackwell  
Date Published: 2015-12-01
Start Page: 8
Language: English
ACCESSION: WOS:000366284900017
PROVIDER: wos
PUBMED: 26492557
DOI: 10.1111/bju.13365
Notes: Meeting Abstract -- 14th International Kidney Cancer Symposium -- NOV 06-07, 2015 -- Miami, FL -- SI -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer